![](/documents/10803/10052828/summer-student-research-day-2022-thumbnail.jpg/2ffb16dd-36ad-494e-db22-43d026c9242b?t=1660655271180)
Summer Student Research Day returns to the RI-MUHC
A diverse group of young research trainees present their summer projects
![](/documents/10803/9944840/parasitic-worms-immune-system-thumbnail.png/66dd05d8-8da9-7b74-4688-6c0483f05434?t=1660227187241)
Parasitic worms reprogram intestinal stem cells to evade the immune system
A new collaboration between immunoparasitologists and stem cell biologists at the RI-MUHC describes...
![](/documents/10803/9596867/dr-foulkes-prize-thumbnail.jpg/95c556f2-4665-a4c3-bb76-c2f272272a1b?t=1659103549942)
RI-MUHC cancer genetics expert honoured by UBC
Dr. William Foulkes receives the 2022 Dr. Chew Wei Memorial Prize in Cancer Research
![](/documents/10803/8864844/dr-lapointe-metabolism-thumbnail.jpg/fbd22f72-d4b4-441b-210f-739667384890?t=1656510933386)
RI-MUHC study highlights the role of fat metabolism enzyme in aggressive prostate cancer
A fatty acid metabolism enzyme drives prostate cancer aggressiveness...
![](/documents/10803/7798827/trainee-vanier-scholarship-thumbnail.jpg/1592293a-4b02-daa7-195c-d342b62504b2?t=1652460167510)
RI-MUHC trainee awarded 2022 Vanier Canada Graduate Scholarship
Joan Miguel Romero is investigating T cell−inflammation in pancreatic cancer
![](/documents/10803/7796850/dr-labbe-study-thumbnail.jpg/62b6085f-5d08-4020-5d28-cf99b6f39ba6?t=1652446801550)
RI-MUHC leads study to identify a novel mechanism driving aggressive prostate cancer
This international research collaboration may lead to a shift in the clinical management of patients...
![](/documents/10803/6446995/study-impact-covid-thumbnail.jpg/3691f682-59b1-a8bb-ba56-53ab74427b82?t=1651154809906)
$6.7 million to study the impacts of COVID-19 on children
Health Minister Jean-Yves Duclos visits Montreal to announce a new investment in pediatric research and to congratulate researcher...
![](/documents/10803/6446995/dr-spicer-immunotherapy-thumbnail.jpg/8548e100-6f03-0f61-b67e-8c6a43fe6784?t=1650475592428)
Immunotherapy showing significant advancements in lung cancer treatment
Phase 3 clinical trial of neoadjuvant nivolumab leads to practice-changing results
![](/documents/10803/6446995/dr-watson-immune-cells-thumbnail-01.jpg/6e8d3a50-3c5e-f389-3b3a-892db689b47c?t=1648841566981)
Where immune cells are located is critical for cancer immune therapy, a new study shows
An innovative new approach highlights the relevance of immune cells’ position within melanoma to inform on a...
![](/documents/10803/6290859/dr-lebrun-discovery-thumbnail.jpg/abaa2a0e-d597-d192-fb98-f3265c7a94a4?t=1647959096083)
RI-MUHC team receives Discovery of the Year Award from Québec Science magazine
Jean-Jacques Lebrun’s team at the RI-MUHC has won the 2021 Québec Science Discovery of the Year Award...